Leishmaniasis is a parasitic disease caused by protozoan parasites from the genus *Leishmania.* Infected host may exhibit from destructive skin lesions to an often fatal, if untreated, visceral disease. Infections are acquired via the bite of female sandflies (Diptera, Psychodidae, Phlebotominae) and the genus *Lutzomyia* is the predominant leishmaniasis vector in South America. During a blood meal, sandfly lacerates capillaries forming a haemor-rhagic pool upon which it feeds, inoculates saliva and regurgitates *Leishmania* metacyclic promastigote forms. Sandfly saliva possesses an array of pharmacologically active compounds, which helps to locate blood vessels and to disrupt the host haemostatic process ([@B26], [@B17]). Haemostasis includes several pathways towards overcoming blood loss, including vasoconstriction, platelet aggregation and blood coagulation. Several insect salivary molecules have been identified as responsible to counteract host haemostasis. Salivary anticoagulants seem to target specific proteases or enzymatic complexes of the blood coagulation cascade, thus blocking or delaying clot formation and allowing the blood feeder to complete the meal ([@B23], [@B17]). A number of anticoagulant proteins have been identified in *Lutzomyia longipalpis* saliva by employing molecular biology and biochemical approaches: a family of coagulation inhibitors belonging to the C-type lectin-like family ([@B05], [@B31]) and, more recently, a novel factor Xa specific inhibitor, named lufaxin ([@B06]).

Apoptotic mimicry has been described in a number of pathological organisms, including virus and trypanosomatids ([@B35], [@B18], [@B27]). This phenomenon consists in the surface exposure of phosphatidylserine (PS) by viable pathogenic organisms, without death as the necessary outcome. In the case of *Leishmania* , both parasite forms, promastigotes and amastigotes, expose PS on their surface, which is an important factor for infection establishment and maintenance, since it contributes for modulating the host\'s immune response ([@B33]).

Exposure of PS by activated platelets has been recog-nised as a crucial step during physiological blood coagulation process ([@B12], [@B19]). In fact, anionic phospholipids facilitate the assembly and activation of multimolecular enzymatic complexes, responsible for activation of blood clotting zymogens ([@B21]). In this context, pathological exposure of PS by tumour cells ([@B16], [@B20]) or by *Plasmodium falciparum* -infected erythrocytes ([@B10]), for example, favours blood coagulation and contribute to disease progression.

Considering that in the moment of sandfly bite, both saliva and metacyclic promastigotes are injected on a haemorrhagic pool in the host skin and that both seems to have opposite effects on blood coagulation, we investigated here the influence of parasite PS exposure and *Lu. longipalpis* saliva on blood coagulation. Our results show that PS exposure by metacyclic promastigotes results in a procoagulant effect. However, the presence of sandfly saliva counteracts this phenomenon therefore reestablishing the inactivation of the blood coagulation cascade.

MATERIALS AND METHODS
=====================

*Lu. longipalpis and salivary gland lysates (SGL)* - *Lu. longipalpis* were obtained from Santarém and Camará colonies, maintained at the Department of Entomology, Oswaldo Cruz Foundation, Rio de Janeiro (RJ), Brazil. Salivary glands of three-five days-old non blood-fed adult female *Lu. longipalpis* were dissected, transferred to microtubes containing phosphate buffer saline (PBS) and lysed by sonication. The homogenates were centrifuged at 10,000 rpm for 1 min to remove debris and the supernatants were transferred to new tubes and stored to -80ºC until use.

*Parasites* - *Leishmania amazonensis* (MHOM/BR/75/Josefa) was maintained on Schneider Insect\'s Medium supplemented with 10% foetal calf serum and 2% human urine at 26ºC. Metacyclic purification was performed according to Späth and Beverley (2001). Briefly, stationary promastigotes of five-six day cultures were collected, washed and resuspended at 1 x 10 ^8^ /mL density in RPMI-1640. Parasites (4 mL) were then overlaid on 4 mL of Ficoll (10%) in PBS and centrifuged at room temperature (RT) for 10 min at 1,300 *g* with the brake off. Metacyclic forms were collected in the 10% Ficoll layer, washed twice in PBS and resuspended in PBS for assays.

*Reagents* - Factor Xa was purchased from Calbiochem (San Diego, CA, USA). Human factor Va and factor X were purchased from Haematologic Technologies (Essex Junction, VT, USA). Human factor IXa was purchased from American Diagnostica (Greenwich, CT, USA). Human FVIII (Advate) was purchased from Baxter Healthcare Corporation (Westlake Village, CA, USA) and was activated with human thrombin as previously described (Astermark et al. 1992). Chromogenic substrates for factor Xa (S-2765, N-α-benzyloxycarbonyl-D-Arg-Gly-Arg-p-nitroanilide) and thrombin (S-2238, H-D-phenylalanyl-L-pipecolyl-L-arginine-p-nitroanilinedihydrochloride) were purchased from Diapharma (Westchester, OH, USA). Activated partial thromboplastin time (aPTT) (cephalin plus kaolin) and prothrombin time (PT) (thromboplastin with calcium) reagents were from BioMérieux (RJ, Brazil). L-α-phosphatidylcholine (PC) and PS were purchased from Sigma Chemical Co (St Louis, MO, USA). Phospholipid vesicles (PC/PS) composed of 75% PC, 25% PS (w/w) were prepared by sonication. Briefly, phospholipids in chloroform were dried with a stream of N2, resuspended in 50 mM Tris-HCl, 150 mM NaCl, pH 7.5 and sonicated for 2 min.

*Evaluation of plasma coagulation by recalcification time* - Plasma coagulation assays by recalcification time were performed on an Amelung KC4A coagulometer (Labcon, Heppenheim, Germany) using plastic tubes. Human blood samples were collected from healthy donors in 3.8% trisodium citrate (9:1, v/v) and platelet poor plasma was obtained by further centrifugation at 2,000 *g* for 10 min. The procoagulant activity of *L. amazonensis* was evaluated by incubation of plasma (50 µL) with 50 µL of tris buffered saline containing different concentrations of metacyclic promastigotes. After 1 min incubation at 37ºC, plasma clotting was initiated by addition of 100 µL of 12.5 mM CaCl ~2~ and coagulation time was recorded. The anticoagulant activity of *Lu. longipalpis* SGL was evaluated by incubating 50 µL of PBS containing 1 SGL with plasma (50 µL). After 1 min at 37ºC, plasma clotting was initiated by addition of 100 µL of 12.5 mM CaCl ~2~ and coagulation time was recorded. For control, plasma was incubated only with PBS. Assays were also performed upon incubation of SGL (various dilutions) with different concentrations of metacyclic forms of *L. amazonensis.* Plasma clotting was initiated as described above.

*Activated partial aPTT and PT tests* - Clotting times of human plasma were recorded on a coagulometer after activation of either the intrinsic or the extrinsic coagulation pathways. Platelet-poor plasma was incubated with 50 µL of PBS containing or not 1 SGL and 50 µL of aPTT reagent for 2 min at 37ºC. Plasma clotting was started by addition of 100 µL of 12.5 mM CaCl ~2~ and coagulation time was recorded. For PT assays, 50 µL of platelet-poor plasma were incubated with 50 µL of PBS containing or not 1 SGL for 1 min at 37ºC. Reaction was started by addition of 100 µL of PT reagent and the plasma clotting was recorded.

*Flow cytometric analysis* - PS exposure by metacyclic forms of *L. amazonensis* was evaluated by flow cytometric analysis. Parasites were resuspended in annexin V binding buffer (10 mM HEPES, 150 mM NaCl, 2.5 mM CaCl ~2~ , pH 7.2) and further incubated for 15 min at RT with annexin V-Alexa-488 (Molecular Probes, Eugene, OR, USA) according to the instructions of the manufacturer. Propidium iodide (PI) was added to the samples at the moment of acquisition (0.4 µg/mL, final concentration). The samples (10,000 events) were acquired on FACSCalibur and analysed on Cell Quest software.

*Prothrombin activation assay* - Activation of prothrombin by the prothrombinase complex (factor Xa/factor Va/calcium) was performed in 50 mM HEPES, 100 mM NaCl, 5 mM CaCl ~2~ , 1 mg/mL bovine serum albumin (BSA), pH 7.5 (HEPES-BSA buffer), using a previously described discontinuous assay ([@B08]). Factor Xa (10 pM, final concentration) was incubated for 2 min at 37ºC with factor Va (1 nM, final concentration) and PC/PS (20 µM, final concentration) in the presence of serially diluted SGL. Reaction was initiated by addition of prothrombin (0.5 µM, final concentration) and aliquots of 10 µL were transferred into microplate wells containing 40 µL of Tris-ethylenediamine tetraacetic acid (EDTA) buffer (50 mM Tris-HCl, 150 mM NaCl, 20 mM EDTA, 1 mg/mL polyethyleneglycol 6,000, pH 7.5). After addition of 50 µL of 100 µM S-2238 prepared in Tris-EDTA buffer, absorbance at 405 nm was recorded at 37ºC for 20 min at 6 s intervals using a Versamax Microplate Reader (Molecular Devices, Menlo Park, CA, USA) equipped with a microplate mixer and heating system. Controls were performed in the absence of SGL. The ability of metacyclic promastigotes in assembling the prothrombinase complex was evaluated by the incubation of factor Xa (10 pM, final concentration) and factor Va (1 nM, final concentration) for 2 min at 37ºC with *L. amazonensis* in HEPES-BSA buffer. Reaction was initiated by addition of prothrombin (0.5 µM, final concentration) and thrombin formation was evaluated as described. The inhibitory effect of SGL on prothrombinase complex assembled in either PC/PS or *L. amazonensis* was also evaluated. In this case, SGL (at various concentrations) was incubated with factor Xa, factor Va and either PC/PS or *L. amazo-nensis* , before addition of prothrombin.

*Factor X activation assay* - Activation of factor X to factor Xa by the intrinsic tenase complex (factor IXa/factor VIIIa/calcium) was performed in HEPES-BSA buffer, using a previously described discontinuous assay ([@B08]). Factor IXa (0.2 nM, final concentration) was incubated for 2 min at 37ºC with factor VIIIa (10 IU/mL, final concentration) in the presence of serially diluted SGL. Reaction was initiated by addition of factor X (50 nM, final concentration) and after 5 min at RT, aliquots of 25 µL were transferred into microplate wells containing 25 µL of Tris-EDTA. After addition of 50 µL of 200 µM S-2765 prepared in Tris-EDTA buffer, absorbance at 405 nm was recorded, at 37ºC, for 20 min at 6 s intervals using a Versamax Microplate Reader.

*Chromogenic assay for measuring factor Xa activity* - The ability of SGL in interfering with factor Xa catalytic activity was evaluated using a chromogenic assay. FXa (1 nM, final concentration) was incubated for 10 min at RT in the presence of SGL serially diluted in HEPES-BSA buffer. After addition of 50 µL of 200 µM S-2765, absorbance at 405 nm was recorded at 37ºC for 20 min at 6 s intervals in a Versamax Microplate Reader. Controls were performed in the absence of SGL.

*Statistical analysis* - Data were analysed by Student *t* test comparing two groups. The analysis was performed using Prism 3.0 (GraphPad Software). In all cases, results were considered to be significantly different for p *\<* 0.05.

RESULTS
=======

*L. amazonesis metacyclic promastigotes activate blood coagulation in a PS-dependent manner* - A number of studies have reported presence of PS on *Leishmania* parasites ([@B36], [@B13], [@B35], [@B39], [@B09], [@B07]). However this phenomenon has been refuted by other groups that were unable to detect this phospholipid on viable parasites ([@B42], [@B40], [@B41], [@B38]). In this study we demonstrate that metacyclic promastigote forms of *L. amazonensis* expose PS in viable parasites. [Fig. 1A](#f01){ref-type="fig"} shows a parasite population that stains for annexin V, but is negative for labelling with PI, a known marker of cell membrane rupture. PS exposure by *Leishmania* amastigote forms accelerate blood coagulation in vitro, as previously demonstrated in parasites isolated from BALB/c mice lesions ([@B02]). In this study we expand this observation to in vitro generated metacyclic promastigotes. [Fig. 1B](#f01){ref-type="fig"} shows that incubation of human plasma with 10 ^5^ and 10 ^6^ parasites reduced the human plasma coagulation time by 32% and 28%, respectively, as compared to control, thus evidencing a parasite-number dependent procoagulant effect.

Fig. 1:procoagulant activity of Leishmania amazonensis metacyclic promastigotes. A: analysis of phosphatidylserine exposure on metacyclic promastigotes. Parasites were analysed by flow cytometry in a dot plot of Alexa 488 conjugated-annexin V vs. propidium iodide (PI) double staining. Quadrant regions were defined from a negative control with no labelling. Data are representative of two independent experiments; B: recalcification time of human plasma was measured in the absence (CT) or in the presence of different numbers of metacyclic promastigotes. Results from 10 independent experiments are expressed as mean ± standard error of the means (SEM). Asterisks mean p \< 0.01 relative to CT; C: L. amazonensis metacyclic promastigotes support the prothrombinase complex assembly. Activation of prothrombin into thrombin by factor Xa/factor Va was performed in the absence or in the presence of logarithmic or metacyclic promastigotes. The amount of thrombin formed was quantified as described in the Materials and Methods section. Data from three independent experiments are expressed as mean ± SEM; D: annexin V blocks the assembly of the prothrombinase complex on L. amazonensis . Metacyclic promastigotes were pre-incubated with different concentrations of annexin V and further assayed for thrombin generation in the presence of factor Xa/factor Va as described in the Materials and Methods section. Data from three independent experiments are expressed as mean ± SEM. Data were analysed by Student t test.

Thrombin is the last enzyme generated in the clotting cascade. It is generated by the cleavage of prothrombin by prothrombinase complex, which consists in a calcium-dependent, membrane-assembled complex between the enzyme factor Xa and its cofactor factor Va. Assembly of the prothrombinase complex on PS-containing membranes is essential to achieve a high catalytic efficiency ([@B21]). In order to confirm PS exposure in *L. amazonensis,* we further evaluated the ability of parasites in promoting thrombin formation by the prothrombinase complex. [Fig. 1C](#f01){ref-type="fig"} shows that metacyclic promastigotes, but not logarithmic promastigotes, support the coagulation complex assembly resulting in prothrombin activation into thrombin. This process was highly dependent on PS exposure, since pre-incubation of parasites with annexin V completely blocked thrombin formation ([Fig. 1D](#f01){ref-type="fig"}).

*Lu. longipalpis saliva counteracts L. amazonensis procoagulant activity* - A number of anticoagulant proteins have been identified in *Lu. longipalpis* saliva ([@B05], [@B31], [@B03]). In accordance with these studies, the presence of one SGL caused a 2.5-fold increase in plasma coagulation time, as compared to control in the absence of SGL ([Fig. 2A](#f02){ref-type="fig"}). Next, we investigated the putative coagulation pathways inhibited by SGL by means of the activated partial aPTT and PT tests. Our data showed that the coagulation time was not altered in the presence or in the absence of one SGL as evaluated by the PT test ([Fig. 2A](#f02){ref-type="fig"}), which contains tissue factor and is used to screen the extrinsic pathway. On the other hand, the aPTT test, which is used to evaluate the intrinsic pathway, showed an increase of 25% in the coagulation time when one SGL was added to the reaction medium ([Fig. 2A](#f02){ref-type="fig"}).

Fig. 2:anticoagulant effect of Lutzomyia longipalpis saliva counteracts procoagulant activity of Leishmania amazonensis metacyclic promastigotes. A: anticoagulant activity of sandfly saliva. Recalcification time of human plasma was measured in the absence (CT) or in the presence of salivary gland lysate (SGL). Prothrombin time and thromboplastin time assays were also performed in the absence (CT) or in the presence of SGL. In all cases, one SGL per assay was used. Data from three independent experiments are expressed as mean ± standard error of the means (SEM). Asterisks mean p \< 0.001 or p \< 0.01 relative to CT; B: recalcification time of human plasma was measured in the absence (plasma alone) or in the presence of different numbers of promastigotes, co-incubated or not with 0.5 SGL; C: recalcification time of human plasma was measured in the absence (plasma alone) or in the presence of 10 6 promastigotes, co-incubated or not with different numbers of SGL. In B and C, results from 10 independent experiments are expressed as mean ± SEM. Data were analysed by Student t test. \*: p \< 0.05; \*\*: p \< 0.01 (relative to control).

Considering that the procoagulant activity of *L. amazonensis* metacyclic forms might be deleterious to vector blood feeding ([@B14], [@B28]), we next analysed the counteracting effect of *Lu. longipalpis* saliva on *L. amazonensis* procoagulant activity. [Fig. 2B](#f02){ref-type="fig"} shows that 0.5 SGL efficiently counteracted the procoagulant effect of either 10 ^5^ or 10 ^6^ parasites. Alternatively, assays performed at a fixed concentration of 10 ^6^ parasites and varying SGL amounts showed a dose-dependent inhibitory effect of sandfly saliva ([Fig. 2C](#f02){ref-type="fig"}).

*Sandfly saliva inhibits prothrombinase complex activity* - Plasma coagulation results from the enzymatic cleavage of soluble fibrinogen into an insoluble fibrin polymer. This reaction is specifically catalysed by thrombin in a reaction that is subsequent to massive prothrombin activation by membrane-assembled prothrombinase complex ([@B21]). In this context, we further evaluated the ability of *Lu. longipalpis* saliva in inhibiting the prothrombinase complex. This was assessed by incubating saliva with factor Xa, factor Va and prothrombin in the presence of calcium ions and artificial PC/PS membranes. As shown in [Fig. 3A](#f03){ref-type="fig"}, the presence of increasing SGL concentrations progressively inhibited thrombin formation by PC/PS-assembled prothrombinase complex. We next examined the ability of sandfly saliva to inhibit *L. amazonensis* -assembled prothrombinase complex. [Fig. 3B](#f03){ref-type="fig"} shows that the presence of one SGL efficiently counteracted thrombin formation in all parasite concentrations tested.

Fig. 3:inhibition of prothrombinase complex by Lutzomyia longipalpis saliva. A: activation of prothrombin into thrombin was carried out in the presence of factor Xa, factor Va and L-Î±-phosphatidylcholine (PC)/phosphatidylserine (PS) vesicles as described in the Materials and Methods section. Assays were performed in the presence of serially diluted salivary gland lysate (SGL) or HEPES-bovine serum albumin buffer alone (PC/PS). Data from five independent experiments are expressed as mean ± standard error of the means (SEM) \[\*\*\*: p \< 0.001; \*: p \< 0.05 (relative to control) (PC/PS)\]; B: inhibition of prothrombinase complex by SGL (0.5 equivalent per assay) in the presence of different numbers of Leishmania amazonensis metacyclic promastigotes. A negative control of thrombin generation in the presence of factor Xa/factor Va alone and in the absence of parasites and SGL was also included (CT). Results from three independent experiments are expressed as mean ± SEM. Data were analysed by Student t test. \*\* : p \< 0.01.

*Sandfly saliva inhibits tenase complex and FXa activity* - Activation of zymogen factor X into factor Xa is efficiently catalysed by the intrinsic tenase complex, which consists in a calcium-dependent, membrane-assembled complex between the enzyme factor IXa and its cofactor factor VIIIa ([@B21]). In order to evaluate whether the intrinsic tenase complex is inhibited by sandfly saliva, we incubated factor IXa, factor VIIIa and PC/PS vesicles with serially diluted sandfly saliva. [Fig. 4A](#f04){ref-type="fig"} shows that increasing SGL concentrations progressively decrease factor X activation.

Fig. 4:inhibition of intrinsic tenase complex and factor Xa catalytic activity by Lutzomyia longipalpis saliva. A: activation of factor X was carried out in the presence of factor VIIIa, factor IXa and L-Î±-phosphatidylcholine/phosphatidylserine vesicles as described in the Materials and Methods section. Assays were performed in the presence of serially diluted salivary gland lysate (SGL) or HEPES-bovine serum albumin (BSA) buffer alone (CT). Data from three independent experiments are expressed as mean ± standard error of the means (SEM) (asterisk means p \< 0.05 relative to CT); B: factor Xa catalytic activity was assayed by measuring the cleavage of S-2765 chromogenic substrate in the absence (CT) or in the presence of different numbers of SGL serially diluted in HEPES-BSA buffer. Data from three independent experiments are expressed as mean ± SEM. Data were analysed by Student t test. \*\*: p \< 0.01; \*: p \< 0.05 (relative to CT).

In general, many arthropods anticoagulants target thrombin or factor X and/or factor Xa, this last a nexus of the intrinsic and extrinsic pathways of blood coagulation ([@B04]). In order to evaluate whether the sandfly saliva anticoagulants have a direct effect on factor Xa and can thus contribute to extend the observed coagulation time, chromogenic assays were performed with factor Xa and sandfly saliva. As shown in [Fig. 4B](#f04){ref-type="fig"}, the presence of 0.5 SGL caused a 50% inhibition in factor Xa catalytic activity, thus indicating that the anticoagulant effect of sandfly saliva is, at least in part, related to direct inhibition of factor Xa activity.

DISCUSSION
==========

The loss of membrane asymmetry during programmed cell death, i.e. apoptosis, is typically associated with PS exposure. The presence of PS in *Leishmania* parasites has been reported by a number of groups ([@B36], [@B13], [@B34], [@B39], [@B09], [@B07]) and the phenomenon of PS exposure by viable parasites has been named \"apoptotic mimicry\". This process is often referred to as a strategy of the parasites to evade host inflammatory and immune responses ([@B34], [@B22], [@B18], [@B27]). This process, which resembles PS exposure during apoptosis, consists in the externalisation of PS on living parasite\'s surface. In the case of *Leishmania* it is believed that most of the amastigote forms expose PS without evidences of apoptotic death ([@B02], [@B35]). Interestingly, it has been reported a differential PS exposure between amastigotes isolated from either susceptible or resistant mice ([@B35]). On the other hand, in promastigotes, a subpopulation of metacyclic forms exposes PS due to apoptosis. The recognition of PS-exposing metacyclic promastigotes by phagocytic cells modulates host immune response by eliciting the production of transforming growth factor-beta and interleukin-10, which facilitate the establishment and maintenance of the infection by the non-PS exposing metacyclic forms ([@B32], [@B34]). In this study we demonstrate that metacyclic promastigote forms of *L. amazonensis* expose PS, while not presenting evidences of cell membrane rupture.

PS exposure by activated platelets is an essential phenomenon during physiological haemostasis ([@B12], [@B19]). In fact, PS-containing membranes allow the assembly of multimolecular enzymatic complexes that ultimately lead to thrombin generation and fibrin deposition ([@B21]). As a result of PS exposure, we herein demonstrate that *L. amazonensis* accelerates plasma clotting and supports the assembly of the prothrombin activating complex, prothrombinase. This process was fully dependent of PS exposure since annexin V completely reverted thrombin formation in the presence of *L. amazonensis* . The ability of *L. amazo-nensis* in recruiting and activating coagulation proteins might be correlated with non-haemostatic properties of these proteins. In this context it has been demonstrated that activation of protease-activated receptor-1, known as the thrombin receptor, contribute to *L. amazonensis* infection in macrophages ([@B25]).

Saliva of haematophagous arthropods contains a diverse mixture of compounds that counteracts host haemostasis ([@B26]). These compounds are essential for achieving a successful blood feeding. In this context, [@B05]) have shown that salivary glands from *Lu. longipalpis* displays potent anticoagulant effect. An anti-clotting molecule containing a carbohydrate-recognition domain-like structure, with a C-type (Ca ^+2^ -dependent) lectin domain, similar to the snake venom active proteins has been identified ([@B15]). Six other members of a family of putative anticoagulants were identified on secreted proteins from *Lu. longipalpis* saliva ([@B31]). Our results confirmed the anticoagulant effect of *Lu. longipalpis* saliva. A prolonged aPTT indicated a specific effect in the intrinsic coagulation pathway. However, the effect of saliva towards extrinsic pathway can be eventually underestimated, due to the large amount of thromboplastin reagent that is used in the PT test. This observation agrees with the estimated concentration of the factor Xa inhibitor, lufaxin, which has been recently characterised in the salivary gland of *Lu. longipalpis* ([@B06]). Indeed, our results demonstrate that the anticoagulant effect of sandfly saliva is partially due to the direct inhibition of factor Xa activity, resulting in decreased thrombin formation by prothrombinase complex and decreased factor Xa activity towards a chromogenic substrate. In this context, lufaxin specifically inhibits factor Xa in a tight, reversible, Ca ^+2^ -independent and non-competitive manner ([@B06]). Remarkably, sandfly saliva counteracts *L. amazonensis* procoagulant activity as well as thrombin formation by *L. amazonensis* -assembled prothrombinase complex.

It is important to emphasise that other anticoagulant proteins might exist in the saliva of *Lu. longipalpis* . While anophelines display thrombin-directed anticoagulants, culicine mosquitoes display factor Xa-directed anticoagulants ([@B30], [@B24]). In *Anopheles albimanus* , anophelin, a 6.5 kDa saliva-derived peptide, functions as a specific and tight-binding thrombin inhibitor ([@B10]). In addition, a Kazal-type thrombin inhibitor has been also characterised in *Aedes aegypti* ([@B37]). In the mosquito vector of yellow fever, *Aedes albopictus* , the protein alboserpin, a factor Xa inhibitor, was characterised as an atypical serpin, which binds tightly to factor Xa and also contains high affinity for heparin and interacts with PC and phosphatidyl ethanolamine ([@B03]).

Altogether we conclude that the previously described immunosuppressive properties evoked by PS exposure on *L. amazonensis* parasites are concomitant with procoagulant responses. On the other hand, the potent anticoagulant effect of *Leishmania* parasites\' vector\'s saliva counteracts this effect. Most of the anticoagulant properties of haematophagous organisms are driven against host procoagulant enzymes or multimolecular coagulation complexes. Therefore it is conceivable that vector\'s saliva impairs procoagulant, but not immunosuppressive properties of PS exposing parasites in the first steps of infection. On the other hand, the subsequent spread of the parasite on the vertebrate host possibly unmasks the procoagulant properties of PS exposing parasites which may evoke important biological responses during *Leishmania* infection.
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